Skip to main content

Endocrine Diseases

  • Reference work entry
  • First Online:
Braun-Falco´s Dermatology
  • 72 Accesses

Abstract

Diseases of endocrine organs and altered secretion of hormones are often associated with characteristic skin lesions. The skin’s ability to react to changes in hormone levels depends on the expression of specific receptors, which fluctuates considerably depending on the skin area. Otherwise, additional factors such as blood circulation, trauma, UV exposure, and the microbiome play an important role. The skin can be the site of pathological changes that occur primarily in an endocrine organ. This is the case with autoimmune diseases, where humoral or cellular immune responses can be directed against both an endocrine organ and the skin. Examples are vitiligo in Addison’s disease or autoimmune thyroiditis. Hormone-secreting tumors of other organs can also be associated with typical skin changes. In addition, the skin is able to produce various hormones such as prolactin, thyroid-stimulating hormone (TSH), thyrotropic hormone (TRH), corticotropin-releasing hormone (CRH), melatonin, melanocyte-stimulating hormones (α-, β-, γ-MSH), adrenocorticotropin (ACTH), and endogenous opioids.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

General Information

  • Jabbour SA (2003) Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol 4:315–331

    Article  PubMed  Google Scholar 

  • Jabbour SA (2010) Skin manifestations of hormone-secreting tumors. Dermatol Ther 23:643–650

    Article  PubMed  Google Scholar 

Pituitary Gland

  • Davidovici BB, Orion E, Wolf R (2008) Cutaneous manifestations of pituitary gland diseases. Clin Dermatol 26:288–295

    Article  PubMed  Google Scholar 

  • Dos Santos Junior A, Henriques TB, de Mello MP et al (2015) Hyperprolactinemia in children and adolescents with use of risperidone: clinical and molecular genetic aspects. J Child Adolesc Psychopharmacol 25:738–748

    Article  CAS  PubMed  Google Scholar 

  • Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27:485–534

    Article  CAS  PubMed  Google Scholar 

  • Kanaka bone C, Kogia C, Abdel Naser MB, Chrousos GP (2016) Skin manifestations of growth hormone-induced diseases. Rev Endocr Metab Disord 17:259–267

    Article  Google Scholar 

  • Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355:2558–2573

    Article  CAS  PubMed  Google Scholar 

  • Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I et al (2007) Hypopituitarism. Lancet 369:1461–1470

    Article  CAS  PubMed  Google Scholar 

  • Spain L, Diem S, Larkin J (2016) Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev 44:51–60

    Article  CAS  PubMed  Google Scholar 

  • Tessnow AH, Wilson JD (2011) The changing face of Sheehan’s syndrome. Am J Med Sci 340:402–406

    Article  Google Scholar 

Adrenal Glands

  • Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881–1893

    Article  CAS  PubMed  Google Scholar 

  • Bertherat J, Groussin L, Bertagna X (2006) Mechanisms of disease: adrenocortical tumors – molecular advances and clinical perspectives. Nat Clin Pract Endocrinol Metab 2:632–641

    Article  CAS  PubMed  Google Scholar 

  • Chan LF, Clark AJ, Metherell LA (2008) Familial glucocorticoid deficiency: advances in the molecular understanding of ACTH action. Horm Res 69:75–82

    CAS  PubMed  Google Scholar 

  • Lenders JW, Eisenhofer G, Mannelli M et al (2005) Phaeochromocytoma. Lancet 366:665–675

    Article  PubMed  Google Scholar 

  • Newell-Price J, Bertagna X, Grossman AB et al (2006) Cushing’s syndrome. Lancet 367:1605–1617

    Article  CAS  PubMed  Google Scholar 

  • Nieman LK, Chanco Turner ML (2006) Addison’s disease. Clin Dermatol 24:276–280

    Article  PubMed  Google Scholar 

  • Schreuer M, Jansen Y, Planken S, Chevolet I, Kruse V, Neyns B (2017) Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreared patients with advanced BRAF V600 mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial. Lancet Oncol 18:464–472

    Article  CAS  PubMed  Google Scholar 

  • Sutter JA, Grimberg A (2006) Adrenocortical tumors and hyperplasias in childhood – etiology, genetics, clinical presentation and therapy. Endocr Rev 4:32–39

    Google Scholar 

Gonads

  • Massart F, Saggese G (2010) Oestrogenic mycotoxin exposures and precocious pubertal development. Int J Androl 33:369–376

    Article  CAS  PubMed  Google Scholar 

  • Merke DP, Bornstein SR (2005) Congenital adrenal hyperplasia. Lancet 365:2125–2136

    Article  PubMed  Google Scholar 

  • Norman RJ, Dewailly D, Legro RS et al (2007) Polycystic ovary syndrome. Lancet 370:685–697

    Article  CAS  PubMed  Google Scholar 

  • Ranasinghe GC, Piliang MP, Bergfeld WF (2017) Prevalence of hormonal and endocrine dysfunctionin patients with lichen planopilaris (LPP): a retrospective data analysis of 168 patients. J Am Acad Dermatol 76:314–320

    Article  CAS  PubMed  Google Scholar 

  • Yildiz BO (2006) Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab 20:167–176

    Article  CAS  PubMed  Google Scholar 

Thyroid Gland and Parathyroid Gland

  • Bodo E, Kany B, Gaspar E et al (2010) Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology 151:1633–1642

    Article  CAS  PubMed  Google Scholar 

  • Brent GA (2008) Clinical practice. Graves’ disease. N Engl J Med 358:2594–2605

    Article  CAS  PubMed  Google Scholar 

  • Chaker L, Bianco AC, Jonklaas J, Peeters RP (2017) Hypothyroidism. Lancet 6736:30703

    Google Scholar 

  • Fuleihan GH, Rubeiz N (2006) Dermatologic manifestations of parathyroid-related disorders. Clin Dermatol 24:281–288

    Article  Google Scholar 

  • Grüter-Kieslich A (2011) Angeborene Hypothyreose und Struma. In: Michalk D, Schönau M (eds) Differentialdiagnose Pädiatrie, 3rd edn. Elsevier, München, pp S 508–S 513

    Chapter  Google Scholar 

  • Spritz RA (2010) Shared genetic relationships underlying generalized Vitiligo and autoimmune thyroid disease. Thyroid 7:745–754

    Article  Google Scholar 

Pancreas

  • Byun DJ, Wolchock JD, Rosenberg LM, Girotra M (2017) Cancer immunotherapy – immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol 13:195–207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cavanagh PR, Lipsky BA, Bradbury AW et al (2005) Treatment for diabetic foot ulcers. Lancet 366:1725–1735

    Article  PubMed  Google Scholar 

  • Morgan AJ, Schwartz RA (2008) Diabetic dermopathy: a subtle sign with grave implications. J Am Acad Dermatol 58:447–451

    Article  PubMed  Google Scholar 

  • Sehgal V, Bhattacharya S, Verma P (2011) Juvenile, insulin-dependent diabetes mellitus, type 1-related dermatoses. J Eur Acad Dermatol Venereol 25:625–636

    Article  CAS  PubMed  Google Scholar 

Polyendocrine Diseases

  • Bell HK, Poston GJ, Vora J et al (2005) Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol 152:71–75

    Article  CAS  PubMed  Google Scholar 

  • Betterle C, Dal Pra C, Mantero F et al (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364

    Article  CAS  PubMed  Google Scholar 

  • Lakhani VT, You YN, Wells SA (2007) The multiple endocrine neoplasia syndromes. Annu Rev Med 58:253–265

    Article  CAS  PubMed  Google Scholar 

  • Michels AW, Gottlieb PA (2010) Autoimmune polyglandular syndromes. Nat Rev Endocrinol 5:270–277

    Article  Google Scholar 

First Describer

  • Addison T (1849) Chronic suprarenal insufficiency, usually due to tuberculosis of suprarenal capsule. Lond Med Gaz 8:517–518

    Google Scholar 

  • Allgrove J, Clayden GS, Grant DB (1978) Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1:1284–1286

    Article  CAS  PubMed  Google Scholar 

  • Binkley GW (1965) Dermopathy in thediabeticsyndrome. Arch Dermatol 92:625–634

    Article  CAS  PubMed  Google Scholar 

  • Braun-Falco O, Petzoldt D (1967) E.M.O.-Syndrom. Exophthalmus -Myxoedema circumscriptum praetibiale -Osteoarthropathia hypertrophicans. Münch Med Wochenschr 109:1523–1529

    CAS  PubMed  Google Scholar 

  • Conn JW (1955) Primary aldosteronism. J Lab Clin Med 45:661–664

    CAS  PubMed  Google Scholar 

  • Cushing’s H (1932) The pituitary body and its disorders. Lippincott, Philadelphia

    Google Scholar 

  • Diamond MT (1959) The syndrome of exophthalmos, hypertrophic osteoarthropathy and localized myxedema: a review of the literature and report of a case. Ann Intern Med 50:206–213

    Article  CAS  PubMed  Google Scholar 

  • Graves RJ (1835) Clinical lectures delivered at the meath hospital during the session 1834–1835. Lecture XII. Newly observed affection of the thyroid. Lond Med Surg 7:515–523

    Google Scholar 

  • Hashimoto H (1912) Zur Kenntnis der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Klin Chir 97:219–248

    Google Scholar 

  • Huntley AC (1986) Finger pebbles: a common finding in diabetes mellitus. J Am Acad Dermatol 14:612–617

    Article  CAS  PubMed  Google Scholar 

  • Krude H, Biebermann H, Luck W et al (1999) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155–157

    Article  Google Scholar 

  • Marie P (1886) Sur deux cus d’acromégalie. Hypertrophy does not affect the congenital extrénitale of supérieures, inférienres and céphalique. Rev Med 6:297–333

    Google Scholar 

  • Melin H (1964) An atrophic circumscribed skin lesion in the lower extremities of diabetics. Acta Med Scand 176:1–75

    Google Scholar 

  • Nelson DH, Meakin JW, Dealy JB Jr et al (1958) ACTH producing tumor of the pituitary gland. N Engl J Med 259:161–164

    Article  CAS  PubMed  Google Scholar 

  • Schmidt MB (1926) Eine biglanduläre Erkrankung (Nebenniere und Schilddrüse) bei Morbus Addisonii. Verh Dtsch Pathol Ges 21:212–221

    Google Scholar 

  • Sheehan HL (1937) Postpertum necrosis of anterior pituitary. J Pathol Bacteriol 45:189–214

    Article  CAS  Google Scholar 

  • Simmonds M (1914) Über Hypophysisschwund mit tödlichem Ausgang. Dtsch Med Wochenschr 40:322–323

    Article  Google Scholar 

  • Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181–191

    Article  Google Scholar 

  • von Basedow CA (1840) Exophthalmus durch Hypertrophie des Zellgewebes in der Augenhöhle. Wochenschr Ges Heilkd 6:197–204

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Luger .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer-Verlag GmbH Germany, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Luger, T., Böhm, M. (2022). Endocrine Diseases. In: Plewig, G., French, L., Ruzicka, T., Kaufmann, R., Hertl, M. (eds) Braun-Falco´s Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63709-8_98

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-63709-8_98

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-63708-1

  • Online ISBN: 978-3-662-63709-8

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics